Ortega GAA, Vargas BJ, Roldán FJ, Arauz GA, Romero CA

Language: Spanish
References: 19
Page: 136-140
PDF size: 244.87 Kb.

ABSTRACT

The potential cardioembolic sources for ischemic stroke in patients younger than 40 years could be asymptomatic. The purpose of this study is to justify routine implementation of transesophageal echocardiography (TEE) in the study of young patients with ischemic stroke. Material and methods: 34 patients younger than 40 years with ischemic stroke were studied with TEE complemented with contrast study, looking for potential cardioembolic sources or intracardiac shunts. Results: 19 patiens were male and 15 female with ages between 18-40 years (average 31 years). None had cardiac signs or symptoms. Eleven anomalies were detected in 20 patients (58.8%); of these, only 3 were considered as probably coursing with cardioembolic sources: patent foramen ovale (PFO), mitral valve prolapse, and ventricular enlargement, which were found in 12 patients (35.29%). In patients with cardiovascular anomalies, we found a hypercoagulable state, associated in eight patients with PFO (four patients), two with valvular thickening, and two with valvular nodules. Conclusions: In patients younger than 40 years with ischemic stroke, TEE is useful in detecting direct and indirect cardiac sources of embolism, even in those patients with unsuspected cardiac disease.

REFERENCES

1. United States agency for Health Care Policy and Research. Post-stroke rehabilitation guideline panel. Clinical practice guidelines. Rockville, MD: U: S: Department of Health and Human services, 1995. AHCPR publication No. 92-0032.

2. Hinchey J, Furlan A, Barnett H: Cardiogenic brain embolism: incidence; varieties and treatment. In: Barnett HJM, Mohr JP, Stein B, Yatsu FM “Stroke, Pathophysiology, Diagnosis and Management”. Ed 3., Philadelphia. Churchill-Livingstone, 1998; 1089.

3. Cianciulli T, Prezioso H, Lax J: Ecocardiografía clínica. Fuentes embolígenas cardiovasculares. En: Barrero C, Gimeno G, Liniado G, Mauro V. Cardiología 2000". Buenos Aires. Médica Panamericana, 1997; 643-689.

4. Adams H, Bendixen B, Kappelle L, Biller J, Lobe B, Gordon D, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter trial. Stroke 1993; 24: 35-41.

5. Kistler J, Furie K: Patent foramen ovale diameter and embolic stroke: A part of the puzzle? Am J Med 2000; 109: 506-507.

6. 6 Kapral M, Silver F: Canadian Task Force on preventive health care. Preventive health care, 1999 UPDATE: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke: CMAJ 1999; 161: 989-96.

7. McNamara R, Lima J, Whelton P, Powe H: Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke. A cost- effectiveness analysis. Ann Intern Med 1997; 127: 775-787.

8. Husain AM, Alter M: Transesophageal echocardiography in diagnosing cardioembolic stroke. Clin Cardiol 1995; 18: 705-708.

9. Alpert J, Armstrong W, Aurigemma G, Beller G, Bierman F, Davidson T, et al: ACC/AHA Guidelines for the clinical application of echocardiography. A report of the American College of Cardiology American Hearth Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). JACC 1997; 29: 862-879.

10. Goldstein M, Barnett H, Orgogozo JM, Sartorius N, Symon L: Stroke-1989: Recommendations on stroke prevention, diagnosis and therapy. Report of the WHO Task Force on stroke and other cerebrovascular disorders. Stroke 1989; 20: 1407-1431.

11. Wein T, Bornstein N: Stroke Prevention. Cardiac and Carotid-related stroke. Neurologic Clinics. Houston, Sauders Co, 2000.

12. Schuchienz H, Weihs W, Horner S, Quehenberger F: The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000; 109: 456-462.

13. De Castro S, Cartoni D, Fiorelli M, Rasura M, Beni S, Urani C, et al: Patent Foramen ovale and its embolic implicationes. Am J Cardiol 2000; 86: 51G-52G.

14. Brickner E: Cardioembolic stroke. Am J Med 1995; 100: 465-474.

15. Barinagarrementería F, Cantú C, De la Peña A, Izaguirre R: Prothrombotic states in young people with idiopathic stroke. A prospective study. Stroke 1994; 25: 287-290.

16. Espinola N, Vargas J, Colmenares T, Cruz F, Romero A, Keirns C, Amigo MC: Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 1999; 137: 974-979.

17. Brenner B, Blumfeld Z, Markiewicz W: Cardiac involvement in patients with primary antiphospholipid syndrome. JACC 1991; 181: 931-936.

18. Hasselaar P, Derkson R, Oosting JD: Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured cells. Thromb Haemost 1989; 62: 654-660.

19. García R, Amigo MC, De la Rosa A: Valvular Heart disease in primary antiphospholipid syndrome: clinical and morphologial findings. Lupus 1996; 5: 56-61.